Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Accelerated Phase × nilotinib × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Philadelphia Chromosome 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Leukemia, Myeloid, Chronic-Phase 2 Synovitis, Pigmented Villonodular 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Leukemia 1 Giant Cell Tumor of Tendon Sheath 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Blast Crisis 1

Interventions

Methotrexate 2 Cyclophosphamide 2 ponatinib 1 pegfilgrastim 1 merphos 1 blinatumomab 1 Vorinostat 1 Vincristine 1 Valganciclovir 1 Therapeutics 1 Tacrolimus 1 Rituximab 1 Polymerase Chain Reaction 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Mycophenolic Acid 1 Granulocyte Colony-Stimulating Factor 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Filgrastim 1 Cytarabine 1 Cyclosporine 1 CT-P10 1 Blood Specimen Collection 1 Antiviral Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡